QSTR with extended topochemical atom (ETA) indices. 13. Modelling of hERG K+ channel blocking activity of diverse functional drugs using different chemometric tools

Molecular Simulation

Volumn 35, Issue 15, 2009, Pages 1256-1268

  Roy, Kunal ^a   Ghosh, Gopinath ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

ETA; FA MLR; HERG; PLS; QSAR; QSTR; Stepwise regression; TAU

Indexed keywords

ETA; FA-MLR; HERG; PLS; QSAR; QSTR; STEPWISE REGRESSION; TAU;

CARBOXYLIC ACIDS; ETHERS; ORGANIC ACIDS; STATISTICAL TESTS; SULFUR COMPOUNDS;

REGRESSION ANALYSIS;

EID: 70449134150     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927020903015379     Document Type: Article

References (65)

1. K.D. Tripathi, Essential Medical Pharmacology, 4th ed., Jaypee Brothers, New Delhi, 1999, pp. 69-70.
2. J. Zurlo, D. Rudacille, and A.M. Goldberg, Animal and Alternatives in Testing: History, Science, and Ethics, Mary Ann Liebert, Inc., New Rochelle, NY, 1994.
3. M.I. Greenberg and S.D. Phillips, A Brief History of Occupational, Industrial and Environmental Toxicology, in Occupational, Industrial and Environmental Toxicology, M.I. Greenberg, R.J. Hamilton, and S.D. Phillips, eds., Mosby, Philadelphia, 2003, pp. 2-5.
4. G. Langley, Acute Toxicity Testing without Animals "More Scientific and Less of a Gamble," European Coalition to End Animal Experiments (ECEAE), London, 2005.
5. D. Garg, T. Gandhi, and C.G. Mohan, Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques, J. Mol. Graph. Mod. 26 (2008), pp. 966-976.
6. J.L. Goldstein, P. Correa, W.W. Zhao, A.M. Burr, R.C. Hubbard, K.M. Verburg, and G.S. Geis, Reduced incidence of gastrodudenal ulcers with celecoxib, a novel cycloxygenase-2 inhibitor, compared to naproxen in patients with arthritis, Am. J. Gastroenterol. 96 (2001), pp. 1019-1027.
7. G.H. Hakimelahi and G.A. Khodarahmi, The identification of toxicophores for the prediction of mutagenicity, hepatotoxicity and cardiotoxicity, J. Iranian Chem. Soc. 2 (2005), pp. 244-267.
8. D. Thomas, C.A. Karle, and J. Kiehn, The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications, Curr. Pharm. Des. 12(18) (2006), pp. 2271-2283.
9. X.L. Zhao, Z.P. Qi, C. Fang, M.H. Chen, Y.J. Lv, B.X. Li, and B.F. Yang, HERG K+ channel blockade by the novel antiviral drug sophocarpine, Biol. Pharm. Bull. 31(4) (2008), pp. 627-632.
10. G.W. Abbott, F. Sesti, I. Splawski, M.E. Buck, M.H. Lehmann, K.W. Timothy, M.T. Keating, and S.A. Goldstein, MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia, Cell 97(2) (1999), pp. 175-187.
11. K.M. Thai and G.F. Ecker, Predictive models for HERG channel blockers: ligand-based and structure-based approaches, Curr. Med. Chem. 14(28) (2007), pp. 3003-3026.
12. A.M. Aronov, Predictive in silico modeling for hERG channel blockers, Drug Discov. Today 10(2) (2005), pp. 149-155.
13. A.M. Aronov, Ligand structural aspects of hERG channel blockade, Curr. Top. Med. Chem. 8(13) (2008), pp. 1113-1127.
14. M.C. Sanguinetti and M. Tristani-Firouzi, hERG potassium channels and cardiac arrhythmia, Nature 440(7083) (2006), pp. 463-469.
15. H. González-D?́az, F. Prado-Prado, and F.M. Ubeira, Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach, Curr. Top. Med. Chem. 8 (2008), pp. 1676-1690.
16. A. Duardo-Sánchez, G. Patlewicz, and A. López-D?́az, Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues, Curr. Top. Med. Chem. 8 (2008), pp. 1666-1675.
17. A.M. Helguera, R.D. Combes, M.P. González, and M.N. Cordeiro, Applications of 2D descriptors in drug design: a DRAGON tale, Curr. Top. Med. Chem. 8 (2008), pp. 1628-1655.
18. M.P. González, C. Terán, L. Sa?́z-Urra, and M. Teijeira, Variable selection methods in QSAR: an overview, Curr. Top. Med. Chem. 8 (2008), pp. 1606-1627.
19. J. Caballero and M. Fernández, Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1), Curr. Top. Med. Chem. 8 (2008), pp. 1580-1605.
20. S. Vilar, G. Cozza, and S. Moro, Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery, Curr. Top. Med. Chem. 8 (2008), pp. 1555-1572.
21. A. Vedani, M. Dobler, and M.A. Lill, The challenge of predicting drug toxicity in silico, Basic Clin. Pharmacol. Toxicol. 99(3) (2006), pp. 195-208.
22. P. Matyus, A.P. Borosy, A. Varro, J.G. Papp, D. Barlocco, and G. Cignarella, Development of pharmacophores for inhibitors of the rapid component of the cardiac delayed rectifier potassium current, Int. J. Quant. Chem. 69 (1998), pp. 21-30.
23. A.P. Borosy, K. Keseru, I. Penzes, and P. Matyus, 3D QSAR study of class I antiarrhythmics, J. Mol. Struct. 503 (2000), pp. 113-129.
24. L.P. Du, K.C. Tsai, M.Y. Li, Q.D. You, and L. Xia, The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents, Bioorg. Med. Chem. Lett. 14 (2004), pp. 4771-4777.
25. S. Ekins, W.J. Crumb, R.D. Sarazan, J.H. Wikel, and S.A. Wrighton, Three dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channels, J. Pharmacol. Exp. Ther. 301 (2002), pp. 427-434.
26. A.M. Aronov, Common pharmacophores for uncharged human ether-ago-go-related gene (hERG) blockers, J. Med. Chem. 49 (2006), pp. 6917-6921.
27. A.O. Aptula and M.T. Cronin, Prediction of hERG K+ blocking potency: application of structural knowledge, SAR QSAR Env. Res. 15(5-6) (2004), pp. 399-411.
28. L.P. Du, K.C. Tsai, M.Y. Li, Q.D. You, and L. Xia, The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents, Bioorg. Med. Chem. Lett. 14(18) (2004), pp. 4771-4777.
29. C. Kramer, B. Beck, J.M. Kriegl, and T. Clark, A composite model for hERG Blockade, ChemMedChem. 3(2) (2008), pp. 254-265.
30. Q. Li, F.S. Jørgensen, T. Oprea, S. Brunak, and O. Taboureau, hERG classification model based on a combination of support vector machine method and GRIND descriptors, Mol. Pharm. 5(1) (2008), pp. 117-127.
31. A. Cavalli, E. Poluzzi, F. De Ponti, and M. Recanatini, Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers, J. Med. Chem. 45 (2002), pp. 3844-3853.
32. H. González-D?́az, S. Vilar, L. Santana, and E. Uriarte, Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices, Curr. Top. Med. Chem. 7 (2007), pp. 1015-1029.
33. H. González-D?́az, Y. González-D?́az, L. Santana, F.M. Ubeira, and E. Uriarte, Proteomics, networks and connectivity indices, Proteomics 8 (2008), pp. 750-778.
34. O. Ivanciuc and A.T. Balaban, The graph description of chemical structures, in Topological Indices and Related Descriptors in QSAR and QSPR, J. Devillers and A.T. Balaban, eds., Gordon and Breach Science Publishers, The Netherlands, 1999, pp. 59-167.
35. K. Roy and G. Ghosh, Introduction of extended topochemical atoms (ETA) indices in the valence electron mobile (VEM) environment as tool for QSAR/QSPR studies, Internet Elect. J. Mol. Des. 2 (2003), pp. 599-620. Available at http://www.biochempress.com.
36. K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. 2. Fish toxicity of substituted benzenes, J. Chem. Inf. Comput. Sci. 44 (2004), pp. 559-567.
37. K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. 3. Toxicity of nitrobenzenes to Tetrahymena pyriformis, QSAR Comb. Sci. 23 (2004), pp. 99-108.
38. K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. 4. Modeling of the acute toxicity of phenylsulfonyl carboxylates to Vibrio fischeri using principal component factor analysis and principal component regression analysis, QSAR Comb. Sci. 23 (2004), pp. 526-535.
39. K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. Part 5. Modeling of the acute toxicity of phenylsulfonyl carboxylates to Vibrio fischeri using genetic function approximation, Bioorg. Med. Chem. 13 (2005), pp. 1185-1194.
40. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. VI. Acute toxicity of benzene derivatives to tadpoles (Rana japonica), J. Mol. Model. 12 (2006), pp. 306-316.
41. K. Roy and I. Sanyal, QSTR with extended topochemical atom indices. 7. QSAR of substituted benzenes to Saccharomyces cerevisiae, QSAR Comb. Sci. 25 (2006), pp. 359-371.
42. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices 8. QSAR for the inhibition of substituted phenols on germination rate of Cucumis sativus using chemometric tools, QSAR Comb. Sci. 25 (2006), pp. 846-859.
43. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. 9. Comparative QSAR for the toxicity of diverse functional organic compounds to Chlorella vulgaris using chemometric tools, Chemosphere 70 (2007), pp. 1-12.
44. K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. 10. Modeling of toxicity of organic chemicals to humans using different chemometric tools, Chem. Biol. Drug Des. 72 (2008), pp. 383-394.
45. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. 11. Comparative QSAR of acute NSAID cytotoxicity in rat hepatocytes using chemometric Tools, Mol. Simul. 35 (2009), pp. 648-659.
46. K. Roy, I. Sanyal, and G. Ghosh, QSPR of n-octanol/water partition coefficient of nonionic organic compounds using extended topochemical atom (ETA) indices, QSAR Comb. Sci. 25 (2006), pp. 629-646.
47. D.K. Pal, C. Sengupta, and A.U. De, A new topochemical descriptor (TAU) in molecular connectivity concept: part I - Aliphatic compounds, Indian J. Chem. 27B (1988), pp. 734-739.
48. D.K. Pal, C. Sengupta, and A.U. De, Introduction of a novel topochemical index and exploitation of group connectivity concept to achieve predictability in QSAR and RDD, Indian J. Chem. 28B (1989), pp. 261-267.
49. D.K. Pal, M. Sengupta, C. Sengupta, and A.U. De, QSAR with TAU (t) indices: Part I - Polymethylene primary diamines as amebicidal agents, Indian J. Chem. 29B (1990), pp. 451-454.
50. D.K. Pal, S.K. Purkayastha, C. Sengupta, and A.U. De, Quantitative structure-property relationships with TAU indices: part I - Research octane numbers of alkane fuel molecules, Indian J. Chem. 31B (1992), pp. 109-114.
51. The GW-BASIC programs RRR98, KRETA1, KRETA2, KRPRES1 and KRPRES2 were developed by Kunal Roy and standardized using known data sets, 1998.
52. Cerius 2 version 4.10 is a product of Accelrys Inc., San Diego, CA, USA. Available at http://www.accelrys.com/cerius2, 2005.
53. F. Franke, Theoretical Drug Design Methods, Elsevier, Amsterdam, 1984, pp. 184-195.
54. R. Franke and P.A. Gruska, Principal component and factor analysis, in Chemometric Methods in Molecular Design, H. van de Waterbeemd, ed., VCH, Weinheim, 1995, pp. 113-163.
55. R.B. Darlington, Regression and Linear Models, McGraw-Hill, New York, NY, 1990.
56. S. Wold and L. Eriksson, Statistical validation of QSAR results, in Chemometric Methods in Molecular Design, H. van deWaterbeemd, ed., VCH, Weinheim, 1995, pp. 312-317.
57. G.M. Sperandio da Silva, C.M. SantLAnna, and E.J. Barreiro, A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors, Bioorg. Med. Chem. 12 (2004), pp. 3159-3166.
58. S.S. Kulkarni and V.M. Kulkarni, Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study, J. Med. Chem. 42 (1999), pp. 373-380.
59. SPSS is statistical software of SPSS, Inc., USA, 1998.
60. MINITAB is a statistical software of MINITAB, Inc., USA.
61. G.W. Snedecor and W.G. Cochran, Statistical Methods, Oxford & IBH Publishing Co. Pvt. Ltd, New Delhi, 1967, pp. 381-418.
62. A.K. Debnath, Quantitative structure-activity relationship (QSAR): A versatile tool in drug design, in Combinatorial Library Design and Evaluation, A.K. Ghose and V.N. Viswanadhan, eds., Marcel Dekker, Inc., New York, NY, 2001, pp. 73-129.
63. J.T. Leonard and K. Roy, On selection of training and test sets for the development of predictive QSAR models, QSAR Comb. Sci. 25 (2006), pp. 235-251.
64. P. Roy and K. Roy, On some aspects of variable selection for partial least squares regression models, QSAR Comb. Sci. 27 (2008), pp. 302-313.
65. B.S. Everitt, S. Landau, and M. Leese, Cluster Analysis, Edward Arnold, London, 2001.